✦ LIBER ✦

Epsilon-Aminocaproic Acid Therapy for Dental Extractions in Haemophilia and Christmas Disease: A Double Blind Controlled Trial

✍ Scribed by P. N. Walsh; C. R. Rizza; J. M. Matthews; J. Eipe; P. B. A. Kernoff; M. D. Coles; A. L. Bloom; B. M. Kaufman; P. Beck; C. M. Hanan; Rosemary Biggs

Book ID: 114707667
Publisher: John Wiley and Sons
Year: 1971
Tongue: English
Weight: 852 KB
Volume: 20
Category: Article
ISSN: 0007-1048
DOI: 10.1111/j.1365-2141.1971.tb07061.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Double-Blind, Placebo-Controlled Trial

A Double-Blind, Placebo-Controlled Trial of Epsilon-Aminocaproic Acid for Reducing Blood Loss in Coronary Artery Bypass Grafting Surgery

✍ Mutsuhito Kikura; Jerrold H. Levy; Kenichi A. Tanaka; James G. Ramsay 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 155 KB

A randomized, double-blind, placebo-cont

A randomized, double-blind, placebo-controlled trial of safinamide as add-on therapy in early Parkinson's disease patients

✍ Fabrizio Stocchi; Rupam Borgohain; Marco Onofrj; Anthony H.V. Schapira; Mohit Bh 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 446 KB 👁 2 views

## Abstract Safinamide is an α‐aminoamide with both dopaminergic and nondopaminergic mechanisms of action evaluated as an add‐on to dopamine agonist (DA) therapy in early‐stage PD. In this 24‐week, double‐blind study, patients with early PD receiving a stable dose of a single DA were randomized to

Ascorbic acid for Charcot–Marie–Tooth di

Ascorbic acid for Charcot–Marie–Tooth disease type 1A in children: a randomised, double-blind, placebo-controlled, safety and efficacy trial

✍ Joshua Burns; Robert A Ouvrier; Eppie M Yiu; Pathma D Joseph; Andrew J Kornberg; 📂 Article 📅 2009 🏛 The Lancet 🌐 English ⚖ 179 KB

T1155 A Randomized Double-Blind Placebo-

T1155 A Randomized Double-Blind Placebo-Controlled Trial of Zoledronic Acid for the Treatment of Osteopenia in Children and Adolescents with Crohn's Disease

✍ Sbrocchi, Anne Marie; Forget, Sylviane; Rodd, Celia 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 107 KB

Safety, efficacy, and biomarker findings

Safety, efficacy, and biomarker findings of PBT2 in targeting Aβ as a modifying therapy for Alzheimer's disease: a phase IIa, double-blind, randomised, placebo-controlled trial

✍ Lars Lannfelt; Kaj Blennow; Henrik Zetterberg; Stellan Batsman; David Ames; John 📂 Article 📅 2008 🏛 The Lancet 🌐 English ⚖ 194 KB